Alleviate Cancer Survivor Distress: Screening and Psychosocial Care
Healthcare providers have a role in improving psychosocial outcomes of cancer survivors by identifying and addressing distress. (Source: Medscape Oncology)
Source: Medscape Oncology - June 20, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Findings From NEMO, and Other Melanoma Highlights
In a preview of ASCO melanoma studies, the NEMO results suggest that binimetinib is reasonable for NRAS-mutated melanoma, and combo regimens continue to show strong outcomes, reports Dr Jeffrey Weber. (Source: Medscape Oncology)
Source: Medscape Oncology - May 31, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Awesome Tips for Navigating ASCO and Chicago
Dr Sheetal Kircher gives tips for making the most out of the American Society of Clinical Oncology (ASCO) annual meeting and enjoying her hometown, Chicago. (Source: Medscape Oncology)
Source: Medscape Oncology - May 23, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Melanoma: ‘Tail’ on Survival Curve Is Getting Longer
Dr Jeffrey Weber, Medscape's new commentator on melanoma and immunotherapy, discusses impressive data on overall survival and combination therapy presented at AACR 2016. (Source: Medscape Oncology)
Source: Medscape Oncology - April 28, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Melanoma: Survival Curve 'Tail' Getting Longer
Dr Jeffrey Weber, Medscape's new commentator on melanoma and immunotherapy, discusses impressive data on overall survival and combination therapy presented at AACR 2016. (Source: Medscape Oncology)
Source: Medscape Oncology - April 28, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
A Biotech Billionaire's Cancer 'Moonshot'
By leading an unprecedented group of companies, institutions, and scientists in Cancer Moonshot 2020, Patrick Soon-Shiong has set out to change cancer care forever. Here's how he plans to do it. (Source: Medscape Oncology)
Source: Medscape Oncology - April 20, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Benefits of Additional Chemo in Residual Breast Cancer
Drs Kathy Miller and Bryan Schneider discuss the surprising CREATE-X findings, which show improved survival using more chemotherapy in triple-negative breast cancer patients with residual disease. (Source: Medscape Oncology)
Source: Medscape Oncology - February 29, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Oncology Burnout: 'Discretionary Time'--What's That?
Does the Medscape Lifestyle Report reflect the real issues of oncologists? Dr Sheetal Kircher takes a survey of her colleagues and finds work-life balance is hard to achieve at all stages of a career. (Source: Medscape Oncology)
Source: Medscape Oncology - February 12, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Pharmacogenetic Testing for 5-FU Saves Lives and Money
Prospective screening for a genetic variant of DPD, an enzyme that catabolizes 5-FU, reduces mortality from 10% to 0% in patients with this variant and is cost-effective. Dr David Kerr is all for it. (Source: Medscape Oncology)
Source: Medscape Oncology - February 5, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Moonshot to Cure Cancer: Hype or Hope?
The Obama Administration's 'moonshot' to cure cancer has drawn both admiration and skepticism among physicians. Dr Maurie Markman talks about what this ambitious effort can, and cannot, achieve. (Source: Medscape Oncology)
Source: Medscape Oncology - January 29, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Does Genetic Test 'Decipher' PCa Risk After Prostatectomy?
The new Decipher genetic test may more accurately predict risk for metastasis following radical prostatectomy for prostate cancer, but will it improve outcomes? (Source: Medscape Oncology)
Source: Medscape Oncology - January 26, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Is Capecitabine New Standard in Pre-op Rectal Cancer?
Dr David Kerr reports on a study in which oral capecitabine beat continuous-infusion 5-FU 'fairly and squarely' in tumor control of early rectal cancer, which may prove a new standard of practice. (Source: Medscape Oncology)
Source: Medscape Oncology - January 15, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
